CHEPLAPHARM

We are pleased to announce that CHEPLAPHARM expands the management with Tamas Szoga as new VP Commercial. As VP Commercial, Tamás Szóga is responsible for the strategic planning and management of the Global Sales division of the entire CHEPLAPHARM Group. This includes developing and implementing strategies to optimise the existing sales organisation and ensuring targeted distributor management. Edeltraud Maria Lafer, CEO of CHEPLAPHARM, says: “The newly created position of VP Commercial demonstrates the importance of this function within the company. I am therefore delighted that we have been able to recruit Tamás Szóga, a leader with two decades of expertise in the development of markets and product portfolios in the pharmaceutical industry." For full information klick here:? https://lnkd.in/ePTdHvpP

We are happy to announce that we are expanding our oncology portfolio by acquiring the treatment Gemzar? from Eli Lilly and Company. Gemzar?is a proven chemotherapeutic agent for the treatment of various types of cancer. The transaction includes the transfer of worldwide commercial rights (except South Korea). https://lnkd.in/eKgFm3Ke

? Part 2 of the workshop is now officially accomplished. After teaming up with Claire Wirdnam (Cento) and The Force CT GmbH again, we’re now a huge step further along our journey to drive organizational development in Supply Chain Management. A very heartfelt thank you goes to the entire work group. Within a cross-functional team, they did not only a fantastic job sharing ideas on organizational structures and processes to move the entire SCM team forward, but also brought their energy, clarity, and enthusiasm into their cooperation with the leadership team (Karl Charly Lang, Patrick Katsoulis, Alexander H?fele, Mathias Krohn, Soeren Sauk). #WeAreSCM

???Werde Teil unseres Teams bei #CHEPLAPHARM!??? Bist du ein #ITEnthusiast, der gerne in einem dynamischen Umfeld arbeitet? Wir suchen einen?Mitarbeiter (m/w/d) für unseren #ITServicedesk am Standort #Berlin, der unser Team verst?rkt und dazu beitr?gt, unsere IT-Dienstleistungen auf das n?chste Level zu heben! ???Das sind Deine Aufgaben bei uns: Erster #Ansprechpartner:?Du bist die erste Anlaufstelle für unsere Mitarbeitenden bei IT-Anfragen und -Problemen. #technischeUnterstützung:?Du diagnostizierst und l?st technische Probleme #Ticketmanagement:?Du verwaltest und priorisierst eingehende Support-Tickets, um eine schnelle L?sung sicherzustellen. #Schulung:?Du erstellst Schulungsmaterialien für unsere Mitarbeitenden Bereit, etwas zu bewegen? Bewirb Dich jetzt! ??? Für weitere Informationen besuche unsere #Karriereseite!

???Werde Teil unseres Teams als Tax Consultant (m/w/d)!??? #CHEPLAPHARM ist ein dynamisches, global agierendes Specialty Pharmaunternehmen, das mit einem nachhaltigen Gesch?ftsmodell auf Wachstumskurs ist und wir suchen Menschen, die nicht nur ihren Job machen, sondern auch etwas bewegen wollen. Das sind deine Aufgaben als #TaxConsultant (m/w/d) bei uns: - Du kümmerst dich um die Erstellung von #Umsatzsteuervoranmeldungen?und sorgst dafür, dass alles reibungslos l?uft - Du unterstützt bei der Erstellung von #Ertragssteuererkl?rungen?und weiteren #Steueranmeldungen, um unsere steuerlichen Verpflichtungen optimal zu erfüllen - Du bist der zentrale Ansprechpartner für alle steuerlichen Fragen?unserer Fachbereiche und externen Berater und stehst ihnen mit Deinem Fachwissen zur Seite Bereit, etwas zu bewegen? Bewirb Dich jetzt! ??? Für weitere Informationen besuche unsere Karriereseite!

Pleased to announce that we’ve been able to attract an experienced financing expert for CHEPLAPHARM: Fabian Kunick has taken over the role of Senior Director Treasury & Investor Relations, leading the two areas in future. Welcome to the team and happy to have you, Fabian!

Wohooo - what a great achievement: Sebastian Frank Braun is EY Entrepreneur of the Year Our Chairman of the Supervisory Board, main owner together with his sister Dr Bianca Juha and former CEO of the CHEPLAPHARM Group was honoured yesterday evening at a gala ceremony at Motorwerk Berlin in the ‘family business’ category. But that's not even all: Sebastian Braun will represent Germany as official nominee at the EY World Entrepreneur Of The Year in Monaco in 2025. Delighted with the award, Sebastian Braun says: ‘Winning this prestigious business award fills me with great pride and I accept it on behalf of my fantastic team. It is the result and at the same time proof of the work we have done together in recent years and a success story that would not have been possible without the CHEPLAPHARM workforce. As the first award winner from Eastern Germany in ten years, I am particularly pleased to have brought the prize home - for our employees, for our company and for the state of Mecklenburg-Vorpommern.’ Congratulations!

Thanks for leading and executing the successful workshop Claire Wirdnam and THE FORCE CT GmbH!

Together with the Universit?t Greifswald, CHEPLAPHARM supports students in the field of pharmacy as part of the #Deutschlandstipendium programme. The scholarship is awarded annually and Jannis Trepczyk has been selected for the 2024/2025 academic year, which is now starting. He is studying pharmacy in his 6th semester and has qualified for the scholarship thanks to his outstanding academic achievements. ‘The Deutschlandstipendium and CHEPLAPHARM offer me the opportunity to realise my goals and develop my talents to the full. I see the scholarship as recognition of my achievements to date and at the same time as motivation to continue to give my best,’ says Jannis, delighted with the scholarship. Happy to support you, Jannis! In the picture: Jannis Trepczyk and Thomas Emmrich, PhD, Senior Director Pharmacovigilance Operations (right) and at the official announcement of the scholarship winners.

Our former CEO, chairman of the supervisory board and main shareholder Sebastian Frank Braun is in the final of the EY Entrepreneur of the Year competition and the winners will be announced in Berlin on 7 November. As part of the award ceremony, the?EY Entrepreneur Of The Year Audience Award?will also be presented - independently of the jury. And the winner is determined very simply: The company that receives the most votes wins. If you think we from CHEPLAPHARM should have a chance to win the audience award, vote for us until 31 October 2024!